• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善肝移植前后的预后:肌肉是改变游戏规则的因素吗?

Improving the prognosis before and after liver transplantation: Is muscle a game changer?

机构信息

Laboratory of Hepato-Gastroenterology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels 1200, Belgium.

Service d'Hépato-Gastroentérologie, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels 1200, Belgium.

出版信息

World J Gastroenterol. 2022 Oct 28;28(40):5807-5817. doi: 10.3748/wjg.v28.i40.5807.

DOI:10.3748/wjg.v28.i40.5807
PMID:36353207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9639652/
Abstract

Liver transplantation (LT) is currently the only curative treatment option for selected patients with end stage liver disease or hepatocellular carcinoma. Improving waiting list-mortality, post-transplant morbidity and mortality and refining the selection of the patients remain our current central objectives. In this field, different concepts dealing with nutrition and the muscle such as sarcopenia, malnutrition, frailty or myosteatosis have emerged as possible game changers. For more than a decade, many prospective studies have demonstrated that sarcopenia and frailty are major predictive factors of mortality in the waiting list but also after LT. Malnutrition is also a well-known risk factor for morbidity and mor-tality. Muscle composition is a newer concept giving insight on muscle quality which has also been shown to be linked to poorer outcomes. Each of these terms has a precise definition as well as pathophysiological mechanisms. The bi-directional liver-muscle axis makes sense in this situation. Defining the best, easy to use in clinical practice tools to assess muscle quality, quantity, and function in this specific population and developing quality prospective studies to identify interventional strategies that could improve these parameters as well as evaluate the effect on mortality are among the important challenges of today.

摘要

肝移植(LT)目前是终末期肝病或肝细胞癌患者的唯一治愈性治疗选择。降低等待名单死亡率、移植后发病率和死亡率,并完善患者选择仍然是我们目前的主要目标。在这一领域,涉及营养和肌肉的不同概念,如肌肉减少症、营养不良、虚弱或肌内脂肪增多症,已成为可能改变游戏规则的因素。十多年来,许多前瞻性研究表明,肌肉减少症和虚弱是等待名单上死亡率的主要预测因素,但也是 LT 后的死亡率的主要预测因素。营养不良也是发病率和死亡率的一个众所周知的危险因素。肌肉组成是一个较新的概念,它提供了关于肌肉质量的深入了解,也表明与较差的结果相关。这些术语中的每一个都有一个精确的定义以及病理生理机制。这种双向的肝-肌肉轴在这种情况下是有意义的。确定最佳的、易于在临床实践中使用的工具来评估该特定人群的肌肉质量、数量和功能,并开展前瞻性研究以确定改善这些参数的干预策略,以及评估对死亡率的影响,是当今的重要挑战之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8317/9639652/27816e43f739/WJG-28-5807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8317/9639652/27816e43f739/WJG-28-5807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8317/9639652/27816e43f739/WJG-28-5807-g001.jpg

相似文献

1
Improving the prognosis before and after liver transplantation: Is muscle a game changer?改善肝移植前后的预后:肌肉是改变游戏规则的因素吗?
World J Gastroenterol. 2022 Oct 28;28(40):5807-5817. doi: 10.3748/wjg.v28.i40.5807.
2
Clinical relevance of sarcopenia in patients with cirrhosis.肝硬化患者中肌肉减少症的临床相关性。
World J Gastroenterol. 2014 Jul 7;20(25):8061-71. doi: 10.3748/wjg.v20.i25.8061.
3
Nutrition and the transplant candidate.营养与移植候选人。
Liver Transpl. 2017 Nov;23(11):1451-1464. doi: 10.1002/lt.24848.
4
Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice?肝硬化患者的营养评估、肌肉减少症和衰弱:临床实践中我们应该使用哪些工具?
Nutrients. 2020 Jan 9;12(1):186. doi: 10.3390/nu12010186.
5
Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?肝硬化患者的衰弱、肌肉减少症和死亡率:哪种评估方法最好,如何正确解读数据,以及有哪些干预措施是可行的?
Clin Res Hepatol Gastroenterol. 2021 Mar;45(2):101661. doi: 10.1016/j.clinre.2021.101661. Epub 2021 Mar 2.
6
Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list.通过整合肌肉减少症评估和等待名单上肝移植候选者的衰弱情况来增强慢加急性肝衰竭的预测。
JHEP Rep. 2023 Dec 19;6(3):100985. doi: 10.1016/j.jhepr.2023.100985. eCollection 2024 Mar.
7
New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients.肝硬化的新概念:肝硬化患者肌肉减少症的临床意义。
Minerva Gastroenterol Dietol. 2013 Jun;59(2):173-86.
8
Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list.终末期肝病患者的运动和体育锻炼:改善等待肝移植期间的功能状态和肌肉减少症。
Liver Transpl. 2018 Jan;24(1):122-139. doi: 10.1002/lt.24958.
9
Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes.减重手术史对肝移植围手术期结局的影响。
Liver Transpl. 2019 Feb;25(2):217-227. doi: 10.1002/lt.25368.
10
Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?肌肉减少症应提高移植优先级还是它是一个禁忌症?
Curr Gastroenterol Rep. 2018 Sep 26;20(11):50. doi: 10.1007/s11894-018-0656-3.

引用本文的文献

1
Update on the Complications and Management of Liver Cirrhosis.肝硬化并发症与管理的最新进展
Med Sci (Basel). 2025 Feb 5;13(1):13. doi: 10.3390/medsci13010013.
2
The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms.肝移植术后胆管损伤对胆管癌及良性疾病复发的影响:危险因素与机制
Cancers (Basel). 2024 Aug 7;16(16):2789. doi: 10.3390/cancers16162789.
3
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis.临床虚弱量表测试的虚弱是肝硬化患者发生肝肾综合征的风险因素。
Clin Transl Gastroenterol. 2022 Jul 1;13(7):e00512. doi: 10.14309/ctg.0000000000000512. Epub 2022 Jun 13.
2
Malnutrition is highly prevalent in hospitalized cirrhotic patients and associates with a poor outcome.营养不良在住院肝硬化患者中非常普遍,并与不良预后相关。
Acta Gastroenterol Belg. 2022 Apr-Jun;85(2):311-319. doi: 10.51821/85.2.9016.
3
Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions.
肌脂肪变性:代谢功能障碍相关脂肪性肝病的诊断、病理生理学及后果
JHEP Rep. 2023 Nov 14;6(2):100963. doi: 10.1016/j.jhepr.2023.100963. eCollection 2024 Feb.
4
Are elevated systemic bile acids involved in the pathophysiology of sarcopenia and liver injury following gastric bypass?胃旁路术后全身性胆汁酸升高是否与肌肉减少症和肝损伤的病理生理学有关?
Acta Gastroenterol Belg. 2023 Apr-Jun;86(2):377-381. doi: 10.51821/86.2.11517.
5
Alcohol Consumption and Skeletal Muscle: What We Know and What We Would Like to Know.饮酒与骨骼肌:我们所知与欲知之事。
Calcif Tissue Int. 2023 Sep;113(3):354-356. doi: 10.1007/s00223-023-01113-z. Epub 2023 Jul 6.
肝硬化性肌内脂肪变性:诊断、病理生理机制及潜在干预措施的综述。
Cells. 2022 Apr 4;11(7):1216. doi: 10.3390/cells11071216.
4
Which preoperative assessment modalities best identify patients who are suitable for enhanced recovery after liver transplantation? A systematic review of the literature and expert panel recommendations.哪些术前评估方式能最好地识别适合肝移植后加速康复的患者?一项文献系统综述及专家小组建议。
Clin Transplant. 2022 Oct;36(10):e14644. doi: 10.1111/ctr.14644.
5
Altered features of body composition in older adults with type 2 diabetes and prediabetes compared with matched controls.与匹配对照相比,2 型糖尿病和糖尿病前期老年患者的身体成分特征改变。
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):1087-1099. doi: 10.1002/jcsm.12957. Epub 2022 Feb 16.
6
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions.肝细胞癌中的肌肉减少症:当前的认识和未来的方向。
World J Gastroenterol. 2022 Jan 28;28(4):432-448. doi: 10.3748/wjg.v28.i4.432.
7
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.肝移植后衰弱、死亡率和医疗保健利用:来自多中心肝移植功能评估(FrAILT)研究。
Hepatology. 2022 Jun;75(6):1471-1479. doi: 10.1002/hep.32268. Epub 2021 Dec 29.
8
Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis.衰弱与肝硬化患者急性肾损伤风险。
Hepatol Commun. 2022 Apr;6(4):910-919. doi: 10.1002/hep4.1840. Epub 2021 Oct 22.
9
Sarcopenia should be evaluated in patients with acute-on-chronic liver failure and candidates for liver transplantation.应评估慢性肝功能衰竭急性发作患者及肝移植候选者是否存在肌肉减少症。
J Hepatol. 2022 Apr;76(4):983-985. doi: 10.1016/j.jhep.2021.09.004. Epub 2021 Sep 15.
10
Frailty is associated with increased risk of cirrhosis disease progression and death.衰弱与肝硬化疾病进展和死亡的风险增加有关。
Hepatology. 2022 Mar;75(3):600-609. doi: 10.1002/hep.32157. Epub 2021 Dec 5.